Home » Stocks » Opthea

Opthea Limited (OPT)

Stock Price: $13.15 USD 0.85 (6.91%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 442.43M
Revenue (ttm) 61,405
Net Income (ttm) -11.62M
Shares Out 43.14M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $13.15
Previous Close $12.30
Change ($) 0.85
Change (%) 6.91%
Day's Open 13.24
Day's Range 12.61 - 13.30
Day's Volume 350,318
52-Week Range 10.22 - 21.36

More Stats

Market Cap 442.43M
Enterprise Value 400.00M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 43.14M
Float n/a
EPS (basic) n/a
EPS (diluted) -0.27
FCF / Share -0.14
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 7,205.09
PB Ratio 6.83
Revenue 61,405
Operating Income -17.55M
Net Income -11.62M
Free Cash Flow -6.06M
Net Cash 42.43M
Net Cash / Share 1.26
Gross Margin 97.80%
Operating Margin -28,578.63%
Profit Margin -18,982.80%
FCF Margin -9,871.72%
ROA n/a
ROE n/a
ROIC -383.00%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions AUD.

Financial Overview

Revenue Growth-45.26%-
Gross Profit0.090.16
Operating Income-25.45-36.75
Net Income-16.53-20.91
Shares Outstanding344-
Earnings Per Share-50.72-71.84
Operating Cash Flow-8.78-24.19
Capital Expenditures-0.01-0.02
Free Cash Flow-8.79-24.20
Cash & Equivalents62.0221.53
Total Debt0.500.03
Net Cash / Debt61.5221.51
Book Value64.8131.12
Numbers in millions AUD, except per-share numbers.

Company Profile

Company Details

Full Name Opthea Limited
Country Australia
Employees 8
CEO Megan Baldwin

Stock Information

Ticker Symbol OPT
Stock Exchange NASDAQ
Sector Health Technology
Industry Pharmaceuticals: Other
Unique Identifier NASDAQ: OPT
IPO Date October 16, 2020


Opthea is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia.